PERAM - Overview: Perampanel, Serum
Monitoring serum concentration of perampanel, in specific clinical conditions (ie, severe kidney impairment, mild to moderate hepatic impairment, and end-stage kidney disease) Assessing compliance Assessing potential toxicity
RPHOC - Overview: Phosphorus, Random, Urine
Evaluation of hypo- or hyperphosphatemic states Evaluation of patients with nephrolithiasis
SOLFM - Overview: Soluble Fibrin Monomer, Plasma
Assisting in the diagnosis of arterial or venous prethrombotic states in various pathological and clinical situations including disseminated intravascular coagulation/intravascular coagulation and fibrinolysis and postoperative monitoring...
SP7TS - Overview: Septin-7 Antibody, Tissue Immunofluorescence Titer, Serum
Detecting septin-7 IgG in serum specimens Reporting an end titer result from serum specimens
DOXA1 - Overview: Oxalate Analysis, Hemodialysate
Determining the amount of oxalate removed during a dialysis session Individualizing the dialysis prescription of hyperoxaluric patients
HBEL0 - Overview: Hemoglobin Electrophoresis Summary Interpretation
Incorporating and summarizing results into an overall evaluation for the HBEL1 / Hemoglobin Electrophoresis Evaluation, Blood
REVE0 - Overview: Erythrocytosis Summary Interpretation
Incorporating and summarizing subsequent results into an overall interpretation for the REVE2 / Erythrocytosis Evaluation, Blood
RKUR - Overview: Potassium, Random, Urine
Determining the cause for hyper- or hypokalemia using a random urine specimen
PDETS - Overview: Phosphodiesterase 10A (PDE10A) IgG, Tissue Immunofluorescence Titer, Serum
Reporting an end titer result from phosphodiesterase 10A (PDE10A) in serum specimens Evaluation of autoimmune/paraneoplastic neurological syndromes among patients presenting with movement disorders and encephalopathy
PDEIS - Overview: Phosphodiesterase 10A (PDE10A) IgG, Tissue Immunofluorescence, Serum
Detecting phosphodiesterase 10A (PDE10A)-IgG in serum specimens Evaluation of autoimmune/paraneoplastic neurological syndromes among patients presenting with movement disorders and encephalopathy
PDEIC - Overview: Phosphodiesterase 10A (PDE10A) IgG, Tissue Immunofluorescence, Spinal Fluid
Detecting phosphodiesterase 10A (PDE10A)-IgG in cerebrospinal fluid specimens Evaluation of autoimmune/paraneoplastic neurological syndromes among patients presenting with movement disorders and encephalopathy
PDETC - Overview: Phosphodiesterase 10A (PDE10A) IgG, Tissue Immunofluorescence Titer, Spinal Fluid
Reporting an end titer result from phosphodiesterase 10A (PDE10A) in spinal fluid specimens Evaluation of autoimmune/paraneoplastic neurological syndromes among patients presenting with movement disorders and encephalopathy
OXYCU - Overview: Oxycodone with Metabolite Confirmation, Random, Urine
Detection and quantification of oxycodone, oxymorphone, noroxycodone, and noroxymorphone in urine
TP - Overview: Protein, Total, Serum
Diagnosis and treatment of a variety of diseases involving the liver, kidney, or bone marrow, as well as other metabolic or nutritional disorders
PARVN - Overview: Parvovirus B19 Antibody, Technical Interpretation
Interpretation of serologic testing for recent or past parvovirus B19 infection This test is not useful as a screening procedure for the general population
TRMP - Overview: Trimipramine, Serum
Monitoring trimipramine concentration during therapy Evaluating potential trimipramine toxicity May aid in evaluating patient compliance
TLB - Overview: Thallium, Blood
Detecting toxic exposure in whole blood specimens
NEGCT - Overview: Negative Control, Technical Component Only
Qualitative detection of protein expression within cells in paraffin-embedded tissues
SP5TC - Overview: Septin-5 Antibody, Tissue Immunofluorescence, Spinal Fluid
Detecting septin-5 IgG in spinal fluid (CSF) specimens Reporting an end titer result from CSF specimens
HYDMU - Overview: Hydromorphone Confirmation, Random, Urine
Detection and quantification of hydromorphone in urine
HYDCU - Overview: Hydrocodone with Metabolite Confirmation, Random, Urine
Detection and quantification of hydrocodone, norhydrocodone, and hydromorphone in urine
FXIII - Overview: Factor XIII (13), Screen, Plasma
Screening for factor XIII deficiency
For the quantitative measurement of human IgA heavy chain and light chain intact immunoglobulin in serum. The result can be used when monitoring previously diagnosed IgA multiple myeloma patients and is used in conjunction with other...
The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Reporting an end titer result from spinal fluid specimens
ALKLC - Overview: Anaplastic Lymphoma Kinase for Lung Cancer, Immunohistochemistry
Identification of anaplastic lymphoma kinase overexpression Diagnosis of inflammatory myofibroblastic tumor, anaplastic large-cell lymphoma, and for targeted therapy of lung adenocarcinoma
AADAM - Overview: ADAMTS13 Profile Interpretation
Technical interpretation of a profile to assist with the diagnosis of congenital, immune, or acquired thrombotic thrombocytopenic purpura including inhibitor studies
RCTUR - Overview: Creatinine, Random, Urine
Calculation of creatinine clearance, a measure of renal function, when used in conjunction with serum creatinine Normalization of urinary analytes by creatinine concentration to account for the variation in urinary concentrations between...
METR1 - Overview: Cytochrome b5 Reductase Enzyme Activity, Blood
Evaluation of patients with cyanosis Confirming cases of suspected cytochrome b5 reductase (methemoglobin reductase) deficiency Functional studies in families with cytochrome b5 reductase deficiency
NCDTS - Overview: Neurochondrin Antibody, Tissue Immunofluorescence Titer, Serum
Detecting neurochondrin-IgG in serum from patients presenting with cerebellar and brainstem syndrome Reporting an end titer result from serum specimens
NOTRP - Overview: Nortriptyline, Serum
Monitoring nortriptyline concentration during therapy Evaluating potential nortriptyline toxicity May aid in evaluating patient compliance
PNYF - Overview: Phenytoin, Free, Serum
Monitoring for appropriate therapeutic concentration of free phenytoin: free phenytoin level is the best indicator of adequate therapy in renal failure Assessing compliance and toxicity
RNAUR - Overview: Sodium, Random, Urine
Assessing acid-base balance, water balance, water intoxication, and dehydration
SORBU - Overview: Sorbitol and Mannitol, Quantitative, Random, Urine
Monitoring effectiveness of treatment in patients with phosphomannomutase 2 deficiency (PMM2-CDG) Establishing a baseline level prior to initiating treatment for PMM2-CDG This test is not useful for diagnosing congenital disorders of...
MEPHS - Overview: Mephobarbital and Phenobarbital, Serum
Monitoring of mephobarbital and phenobarbital therapy
TRAM - Overview: Tramadol and Metabolite, Random, Urine
Monitoring of compliance utilizing tramadol Detection and confirmation of the illicit use of tramadol This test is not intended for use in employment-related testing.
DESPR - Overview: Desipramine, Serum
Monitoring serum concentration of desipramine during therapy Evaluating potential desipramine toxicity May aid in evaluating patient compliance
CHLE - Overview: Cholesteryl Esters, Serum
Establishing a diagnosis of lecithin-cholesterol acyltransferase deficiency Evaluating the extent of metabolic disturbance by bile stasis or liver disease
CRETR - Overview: Creatinine, Random, Urine
Normalization of urinary analytes to account for the variation in urinary concentrations between individuals when using random urine collections
DLAC - Overview: D-Lactate, Plasma
As an adjunct to urine D-lactate (preferred) for the diagnosis of D-lactate acidosis
SP7TC - Overview: Septin-7 Antibody, Tissue Immunofluorescence Titer, Spinal Fluid
Detecting septin-7 IgG in cerebrospinal fluid (CSF) specimens Reporting an end titer result from CSF specimens
PGK1 - Overview: Phosphoglycerate Kinase Enzyme Activity, Blood
Evaluation of individuals with Coombs-negative nonspherocytic hemolytic anemia, especially if X-linked inheritance pattern Evaluation of individuals with myopathic or neurologic symptoms
FRUCT - Overview: Fructosamine, Serum
Monitoring intermediate (1-3 weeks) glycemic control Monitoring glycemic control in patients with shortened red blood cell survival
SP5TS - Overview: Septin-5 Antibody, Tissue Immunofluorescence Titer, Serum
Detecting septin-5 IgG in serum specimens Reporting an end titer result from serum specimens
SDEX - Overview: Sickle Solubility, Blood
Screening for presence or absence of hemoglobin (Hb) S (sickle cell disease)
Quantifying plasma HIV-1 RNA levels (viral load) in individuals (including children) with known HIV-1 infection, followed by identification of HIV-1 genotypic mutations associated with resistance to nucleotide and non-nucleoside...
BLPMF - Overview: B-Cell Lymphoma, Specified FISH, Varies
Detecting, at diagnosis, common chromosome abnormalities associated with specific B-cell lymphoma subtypes using client specified FISH probes
CRHEP - Overview: Chronic Viral Hepatitis (Unknown Type), Serum
Diagnosis and evaluation of patients with symptoms of hepatitis lasting more than 6 months Distinguishing between chronic hepatitis B and C
PHEPU - Overview: Previous Viral Hepatitis (Unknown Type), Serum
Determining if an individual has been infected following exposure to an unknown type of viral hepatitis virus Obtaining baseline serologic markers of an individual exposed to a source with an unknown type of hepatitis Determining...
FRT4 - Overview: T4 (Thyroxine), Free, Serum
Evaluating suspected thyroid function disorders using free thyroxine measured together with thyroid-stimulating hormone
The Region 4 Stork (R4S) Collaborative Project - Insights
describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S....
The Region 4 Stork (R4S) Collaborative Project - Insights
describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S....
The Region 4 Stork (R4S) Collaborative Project - Insights
describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S....
The Region 4 Stork (R4S) Collaborative Project - Insights
describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S....
The Region 4 Stork (R4S) Collaborative Project - Insights
describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S....